Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$314 Sell
786
-1,615
-67% -$826 ﹤0.01% 2508
2026
Q2
$1.24K Buy
2,401
+1,307
+119% +$781 ﹤0.01% 2149
2026
Q1
$688 Sell
1,094
-1,101
-50% -$829 ﹤0.01% 2342
2025
Q4
$1.93K Sell
2,195
-1,519
-41% -$1.62K ﹤0.01% 1818
2025
Q3
$5.05K Buy
3,714
+2,755
+287% +$4.17K ﹤0.01% 1425
2025
Q2
$1.51K Buy
+959
New +$1.79K ﹤0.01% 1399

Other funds holding DCGO

Essential Partners's DCGO Position: Q3 2026 in Review

Essential Partners reduced its DocGo (DCGO) stake by 67% in Q3 2026, selling an estimated $826 and leaving 786 shares worth $314. The position accounts for ﹤0.01% of the portfolio, ranked #2508.

Essential Partners first reported a position in DCGO in Q2 2025 and has held it in 6 quarters since. The position peaked at $5.05K in Q3 2025. 5 funds tracked by Wall St. Rank hold DCGO as of Q3 2026.

  • Essential Partners held 786 shares of DocGo worth $314 as of Q3 2026.
  • Essential Partners sold 1,615 DocGo shares in Q3 2026, an estimated $826.
  • DocGo made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2508 holding.
  • Essential Partners first reported a position in DocGo in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's DocGo position peaked at $5.05K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held DocGo as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.